Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BEAT

HeartBeam Inc

Apr 16 • 04:00PM ET

0.8100

-0.0753 -8.51 %

Healthcare • Health Information Services • USA • NASD

Apr 15, 8:30 PMDilutive $10M public stock offering priced at 33% discount triggers 26% plunge.

Peers: BSX ALGN EW HOLX SYK ISRG IART ZBH PODD NVRO

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-0.63	Insider Own	19.70%	Shs Outstand	40.12M	Perf Week	-31.36%
Market Cap	33.28M	Forward P/E	-	EPS next Y	-0.43	Insider Trans	11.33%	Shs Float	32.99M	Perf Month	-37.69%
Enterprise Value	28.90M	PEG	-	EPS next Q	-0.14	Inst Own	11.12%	Short Float	9.54%	Perf Quarter	-64.63%
Income	-21.02M	P/S	-	EPS this Y	15.66%	Inst Trans	5.65%	Short Ratio	2.39	Perf Half Y	-54.75%
Sales	0.00M	P/B	12.48	EPS next Y	16.92%	ROA	-460.91%	Short Interest	3.15M	Perf YTD	-66.25%
Book/sh	0.06	P/C	7.60	EPS next 5Y	31.15%	ROE	-987.32%	52W High	4.00 -79.75%	Perf Year	-51.20%
Cash/sh	0.11	P/FCF	-	EPS past 3/5Y	26.76% -36.66%	ROIC	-807.34%	52W Low	0.54 50.00%	Perf 3Y	-62.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.45% 6.72%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	14.15%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	26.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.45	EPS Q/Q	20.28%	SMA20	-28.89%	Beta	-0.81	Target Price	5.08
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-37.42%	Rel Volume	1.45	Prev Close	0.89
Employees	16	LT Debt/Eq	0.00	Earnings	Mar 12 AMC	SMA200	-46.32%	Avg Volume	1.32M	Price	0.81
IPO	Nov 11, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-1.82% -	Trades		Volume	1,914,152	Change	-8.51%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-26	Initiated	B. Riley Securities	Buy	$4
Mar-27-26	Initiated	D. Boral Capital	Buy	$5
Mar-16-26	Downgrade	The Benchmark Company	Buy → Speculative Buy	$8
Dec-11-25	Upgrade	The Benchmark Company	Speculative Buy → Buy	$8
Dec-08-25	Initiated	H.C. Wainwright	Buy	$2.50
Oct-31-25	Initiated	Roth Capital	Buy	$4

Apr-15-26 03:30PM	HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives (NewMediaWire) -26.23%
Apr-14-26 10:00PM	HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock (Business Wire)
04:05PM	HeartBeam Announces Proposed Public Offering of Common Stock (Business Wire)
Mar-27-26 09:30AM	How Decentralized AI is Unlocking Value in Cardiac Diagnostics (PR Newswire)
Mar-25-26 03:20PM	HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and Validation (NewMediaWire)
02:12PM	Loading…
Mar-13-26 02:12PM	HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development (NewMediaWire) -7.48%
08:30AM	HeartBeam, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-12-26 11:06PM	HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ... (GuruFocus.com) +8.09%
04:01PM	HeartBeam Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Mar-10-26 02:45PM	HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development (NewMediaWire) -8.78%
09:33AM	Heartbeam Stock Jumps After AI Collaboration With Mount Sinai (Benzinga)
07:00AM	HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home (Business Wire)
Mar-09-26 03:30PM	HeartBeam (BEAT) Management to Participate in March 2026 Investor and Industry Conferences (NewMediaWire) +5.71%
07:00AM	HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch (Business Wire)
Mar-05-26 03:30PM	HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection (NewMediaWire) -8.50%
07:00AM	Loading…
07:00AM	HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study (Business Wire)
Mar-04-26 04:01PM	HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time (Business Wire)
03:30PM	HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio (NewMediaWire)
07:00AM	HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market (Business Wire)
Feb-20-26 03:00PM	HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform (NewMediaWire)
Feb-13-26 03:30PM	HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year (NewMediaWire) +9.02%
Jan-22-26 03:00PM	HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer (NewMediaWire)
07:00AM	HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer (Business Wire)
Jan-09-26 03:40PM	FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup (NewMediaWire)
Jan-05-26 02:30PM	HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference (NewMediaWire) +12.76%
07:00AM	HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference (Business Wire)
Dec-18-25 03:00PM	HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation (NewMediaWire) -11.73%
Dec-11-25 07:17AM	BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System (Zacks) +36.77%
Dec-10-25 03:30PM	HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal (NewMediaWire) +92.43%
07:00AM	HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment (Business Wire)
02:30PM	Loading…
Dec-01-25 02:30PM	HeartBeam (BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software (NewMediaWire) -6.49%
Nov-26-25 04:32PM	HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application (Business Wire) +27.55%
Nov-20-25 03:00PM	HeartBeam (BEAT) Poised in the Future of Cardiac Care With Breakthrough Technology (NewMediaWire)
Nov-14-25 03:30PM	HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates (NewMediaWire)
12:05AM	HeartBeam Inc (BEAT) Q3 2025 Earnings Call Highlights: Innovations and Challenges in Cardiac Care (GuruFocus.com)
Nov-13-25 04:01PM	HeartBeam Reports Third Quarter 2025 Results (Business Wire) -5.99%
Nov-12-25 02:30PM	HeartBeam (BEAT) Recognized as a Top Global Innovator in Portable ECG Technology (NewMediaWire)
07:34AM	Earnings To Watch: HeartBeam Inc (BEAT) Reports Q3 2025 Results (GuruFocus.com)
Oct-30-25 03:00PM	HeartBeam (BEAT) Schedules Third Quarter 2025 Conference Call for November 13 (NewMediaWire)
07:00AM	HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time (Business Wire)
Oct-28-25 03:00PM	HeartBeam (BEAT) Partners With HeartNexus to Deliver 24/7 Remote Cardiology Services and Real-Time ECG Interpretation (NewMediaWire)
07:00AM	HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere (Business Wire)
Oct-17-25 03:30PM	HeartBeam (BEAT) Combining Portability and Precision to Redefine Future of Cardiac Care (NewMediaWire)
Oct-09-25 03:00PM	HeartBeam (BEAT) on the Beat of Cardiac Innovation (NewMediaWire)
Sep-29-25 03:30PM	HeartBeam's (BEAT) ECG System Offers Real-Time Cardiac Insights (NewMediaWire)
Sep-15-25 02:30PM	HeartBeam (BEAT) Prepares Innovative ECG Tech for Commercial Launch (NewMediaWire)
Sep-11-25 02:30PM	HeartBeam (BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System (NewMediaWire)
Sep-09-25 09:24AM	HeartBeam (BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias (NewMediaWire)
Sep-08-25 07:00AM	HeartBeams Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias (Business Wire)
Aug-29-25 02:30PM	HeartBeam (NASDAQ: BEAT) to Present at Three September Investor Conferences (NewMediaWire) +6.30%
Aug-28-25 03:00PM	HeartBeam (NASDAQ: BEAT) Advances Patient Convenience with At-Home ECG Technology (NewMediaWire) +7.63%
Aug-22-25 03:30PM	HeartBeam's (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology (NewMediaWire)
Aug-14-25 03:13AM	HeartBeam Inc (BEAT) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Discipline (GuruFocus.com) -7.50%
Aug-13-25 04:01PM	HeartBeam Reports Second Quarter 2025 Results (Business Wire)
Aug-12-25 09:41AM	Earnings To Watch: HeartBeam Inc (BEAT) Reports Q2 2025 Result (GuruFocus.com) +27.38%
Jul-30-25 07:00AM	HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time (Business Wire)
Jul-22-25 07:00AM	HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology (Business Wire)
Jun-23-25 03:00PM	IBN Coverage: HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection (NewMediaWire)
Jun-20-25 03:30PM	IBN Coverage: HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection (NewMediaWire)
Jun-18-25 03:00PM	IBN Coverage: HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology (NewMediaWire)
Jun-17-25 03:00PM	IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch (NewMediaWire) -9.36%
07:00AM	HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 (Business Wire)
Jun-16-25 03:15PM	IBN Coverage: HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG (NewMediaWire) +13.25%
May-13-25 04:01PM	HeartBeam Reports First Quarter 2025 Results (Business Wire) -6.43%
May-06-25 07:00AM	HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio (Business Wire)
May-05-25 07:00AM	HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth (Business Wire)
May-01-25 08:31AM	HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time (Business Wire)
Apr-29-25 08:31AM	HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology (Business Wire) -7.18%
Apr-24-25 08:31AM	HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation (Business Wire) +20.75%
Mar-13-25 04:01PM	HeartBeam Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Mar-06-25 09:01AM	HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 (Business Wire)
Feb-27-25 08:31AM	HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time (Business Wire)
Feb-25-25 04:01PM	HeartBeam Announces Exercise and Closing of Underwriters Over-Allotment Option for Public Offering of Common Stock (Business Wire)
Feb-13-25 08:31AM	HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock (Business Wire)
Jan-29-25 08:31AM	HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software (Business Wire)
Dec-23-24 08:31AM	HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference (Business Wire)
Dec-16-24 08:31AM	HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology (Business Wire) -13.30%
Nov-19-24 08:31AM	HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference (Business Wire)
Nov-07-24 04:05PM	HeartBeam Reports Third Quarter 2024 Results (Business Wire) -7.17% +10.30%
Oct-31-24 08:31AM	HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time (Business Wire) -10.37%
Oct-24-24 08:31AM	HeartBeam Named Rising Star at the 6th Annual Digital Health Hub Foundation Awards (Business Wire) +6.48%
Oct-17-24 08:31AM	HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization (Business Wire)
Sep-24-24 08:31AM	HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist (Business Wire)
Sep-10-24 08:31AM	HeartBeam Names Timothy Cruickshank as Chief Financial Officer (Business Wire)
Aug-14-24 04:05PM	HeartBeam Reports Second Quarter 2024 Results (Business Wire)
Aug-01-24 08:31AM	HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time (Business Wire) -7.28%
Jul-01-24 08:31AM	HeartBeam Added to Russell Microcap Index (Business Wire)
May-20-24 08:31AM	HeartBeams Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias (Business Wire) +22.22%
May-13-24 08:31AM	HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program (Business Wire)
May-09-24 04:05PM	HeartBeam Reports First Quarter 2024 Results (Business Wire)
Apr-25-24 08:31AM	HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time (Business Wire)
Apr-09-24 08:31AM	HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias (Business Wire)
Mar-20-24 08:53PM	BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023 (InvestorPlace)
04:05PM	HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-14-24 08:31AM	First Patients Enrolled in Pivotal Study Evaluating HeartBeams AIMIGo System for Synthesizing a 12-Lead ECG (Business Wire)
Mar-07-24 08:31AM	HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology (Business Wire) +26.54%
Mar-05-24 08:31AM	HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time (Business Wire) -5.36%
Jan-31-24 09:00AM	MDB Capital Holdings Issues Annual Letter to Shareholders (GlobeNewswire)
Dec-14-23 08:31AM	HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights (Business Wire) +6.61%
Nov-15-23 02:30PM	HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript (Insider Monkey) -9.63%

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cruickshank Tim	CFO	Apr 16 '26	Buy	0.80	31,250	25,000	72,230	Apr 16 08:48 PM
Elfrink Willem	Director	Apr 16 '26	Buy	0.80	187,500	150,000	538,667	Apr 16 08:48 PM
JAFF MICHAEL R	Director	Apr 16 '26	Buy	0.80	31,250	25,000	31,250	Apr 16 08:47 PM
Vajdic Branislav	Director	Apr 16 '26	Buy	0.80	31,250	25,000	909,914	Apr 16 08:47 PM
Ferrari Richard	Director	Apr 16 '26	Buy	0.80	62,500	50,000	291,636	Apr 16 08:47 PM
ENO Robert Paul	President	Apr 16 '26	Buy	0.80	12,500	10,000	36,742	Apr 16 08:47 PM
Ortigas-Wedekind Marga	Director	Apr 16 '26	Buy	0.80	25,000	20,000	137,293	Apr 16 08:46 PM
STROME MARK E	Director	Apr 16 '26	Buy	0.80	750,000	600,000	3,650,000	Apr 16 08:46 PM
STROME MARK E	10% Owner	Dec 17 '25	Sale	3.58	250,000	895,000	2,900,000	Dec 22 05:44 PM
de Urioste George	Director	Dec 18 '25	Sale	2.83	33,185	93,914	0	Dec 19 05:10 PM
de Urioste George	Director	Dec 17 '25	Sale	3.68	23,961	88,176	33,185	Dec 19 05:10 PM

Open in Screener

LUNG

Pulmonx Corp

Apr 16 • 04:00PM ET

1.46

-0.04 -2.67 %

Healthcare • Medical Devices • USA • NASD

Peers: DHR MDT EW ISRG SYK BSX ZBH HOLX XRAY ALGN

| Held by: VTI IWM VXF IWO VTWO IWC ITOT VTWG RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-1.33	Insider Own	13.10%	Shs Outstand	41.67M	Perf Week	7.35%
Market Cap	61.67M	Forward P/E	-	EPS next Y	-0.86	Insider Trans	-2.59%	Shs Float	36.70M	Perf Month	-9.88%
Enterprise Value	48.02M	PEG	-	EPS next Q	-0.33	Inst Own	80.56%	Short Float	7.79%	Perf Quarter	-27.00%
Income	-54.00M	P/S	0.68	EPS this Y	14.54%	Inst Trans	-1.77%	Short Ratio	5.91	Perf Half Y	-7.01%
Sales	90.50M	P/B	1.12	EPS next Y	24.63%	ROA	-35.80%	Short Interest	2.86M	Perf YTD	-33.94%
Book/sh	1.30	P/C	0.88	EPS next 5Y	47.42%	ROE	-77.19%	52W High	5.46 -73.26%	Perf Year	-69.52%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	5.81% -8.01%	ROIC	-49.47%	52W Low	1.13 29.20%	Perf 3Y	-86.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	19.03% 22.55%	Gross Margin	73.97%	Volatility	7.59% 8.55%	Perf 5Y	-96.67%
Dividend TTM	-	EV/Sales	0.53	EPS Y/Y TTM	7.82%	Oper. Margin	-59.30%	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.27	Sales Y/Y TTM	8.01%	Profit Margin	-59.67%	RSI (14)	52.58	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	5.06	EPS Q/Q	24.36%	SMA20	9.28%	Beta	0.27	Target Price	5.17
Payout	-	Debt/Eq	1.04	Sales Q/Q	-4.91%	SMA50	-1.18%	Rel Volume	0.54	Prev Close	1.50
Employees	296	LT Debt/Eq	1.02	Earnings	Apr 29 AMC	SMA200	-21.09%	Avg Volume	483.33K	Price	1.46
IPO	Oct 01, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	35.06% 4.00%	Trades		Volume	262,462	Change	-2.67%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-25	Downgrade	Piper Sandler	Overweight → Neutral	$2.50
Mar-10-25	Initiated	D. Boral Capital	Buy	$17
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$17 → $7.50
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49

Show Previous Ratings

Apr-15-26 04:05PM	Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026 (GlobeNewswire) +5.63%
Mar-05-26 08:30AM	Pulmonx Corporation Q4 2025 Earnings Call Summary (Moby) +11.81%
12:02AM	Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... (GuruFocus.com)
Mar-04-26 07:00PM	Pulmonx Q4 Earnings Call Highlights (MarketBeat) -5.88%
05:35PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Loading…
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Closing of up to $60 Million Credit Facility (GlobeNewswire)
Feb-27-26 08:15AM	Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates (Zacks)
Feb-26-26 08:15AM	Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-20-26 08:00AM	Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 (GlobeNewswire) +5.99%
Dec-03-25 04:05PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.00% +13.23%
Nov-13-25 12:01AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... (GuruFocus.com) -18.88%
Nov-12-25 05:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.22%
04:05PM	Pulmonx Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:15PM	American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.01%
05:43AM	Loading…
Oct-31-25 05:43AM	Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? (Insider Monkey) +13.64%
Oct-28-25 10:03AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +26.92%
Oct-27-25 04:05PM	Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 (GlobeNewswire)
Oct-15-25 04:05PM	Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 (GlobeNewswire)
Aug-27-25 12:00PM	What Makes Pulmonx (LUNG) a New Buy Stock (Zacks) +5.08%
Aug-26-25 04:05PM	Pulmonx to Participate in September Investor Conferences (GlobeNewswire) +5.99%
Aug-11-25 05:00AM	Apreo raises $130M for pivotal trial of emphysema device (MedTech Dive)
Aug-05-25 09:35AM	After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) (Zacks)
Jul-31-25 03:33AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges (GuruFocus.com) -41.59%
Jul-30-25 06:00PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 04:05PM	Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
10:05AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-16-25 04:05PM	Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 (GlobeNewswire) +7.78% +6.19%
May-28-25 04:05PM	Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +8.11%
11:00AM	Loading…
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
May-01-25 04:05PM	Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire) -21.95%
10:06AM	Q1 2025 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... (GuruFocus.com)
Apr-30-25 08:25PM	Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript (Seeking Alpha) -8.35%
06:10PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 04:05PM	Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025 (GlobeNewswire) -5.64%
06:53AM	P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Feb-20-25 01:14PM	Q4 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +32.23%
02:12AM	Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com)
Feb-19-25 05:20PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.01%
04:05PM	Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
04:58AM	What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 04:05PM	Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day (GlobeNewswire) +5.28% -5.56%
Feb-05-25 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire) +6.59%
Nov-21-24 09:55AM	Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? (Zacks)
Nov-20-24 04:05PM	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 09:00AM	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers (Business Wire)
Nov-07-24 04:05PM	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-24 04:05PM	Pulmonx to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire) +8.44%
09:55AM	Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know (Zacks)
Oct-31-24 07:00AM	Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com) -7.95%
Oct-30-24 06:25PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 04:05PM	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire) -5.74%
Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-07-24 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Dec-22-23 11:19PM	Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Dec-11-23 09:00AM	The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors (GlobeNewswire)
Nov-17-23 01:08PM	Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare (InvestorPlace)
Nov-15-23 04:05PM	Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Oct-31-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire) +11.41%
09:00AM	Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:03AM	Q3 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-23 06:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:53PM	Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results (GuruFocus.com)
04:05PM	Pulmonx Reports Record Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:05PM	Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023 (GlobeNewswire)
Oct-10-23 04:05PM	Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue (GlobeNewswire) -13.36%

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Radhakrishnan Srikanth	Chief Science &Techn. Officer	Mar 02 '26	Sale	1.43	10,483	14,991	170,736	Mar 04 07:07 PM
French Glendon E. III	President and CEO	Mar 02 '26	Sale	1.43	67,813	96,973	1,409,511	Mar 04 07:06 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 02 '26	Sale	1.43	7,732	11,057	365,734	Mar 04 07:04 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 02 '26	Sale	1.43	12,237	17,499	240,755	Mar 04 07:01 PM
STEVEN WILLIAMSON	Officer	Jan 22 '26	Proposed Sale	1.95	48,892	95,339		Jan 22 04:02 PM
STEVEN WILLIAMSON	Officer	Jan 15 '26	Proposed Sale	1.95	15,892	31,039		Jan 15 05:49 PM
STEVEN WILLIAMSON	Officer	Jan 14 '26	Proposed Sale	2.00	31,082	62,074		Jan 14 05:13 PM
Florin Daniel P	Director	Dec 08 '25	Sale	1.99	23,321	46,409	93,910	Dec 09 05:59 PM
DANIEL P FLORIN	Director	Dec 08 '25	Proposed Sale	1.99	23,321	46,385		Dec 08 06:26 PM
French Glendon E. III	President and CEO	Dec 01 '25	Sale	1.57	8,805	13,824	277,324	Dec 03 07:51 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Dec 01 '25	Sale	1.57	6,322	9,926	373,466	Dec 03 07:48 PM
Lehman David Aaron	GENERAL COUNSEL	Dec 01 '25	Sale	1.57	10,278	16,136	252,992	Dec 03 07:43 PM
Williamson Steven S.	PRESIDENT AND CEO	Sep 02 '25	Sale	1.60	9,648	15,437	358,967	Sep 03 05:14 PM
Joshi Mehul	Chief Financial Officer & PAO	Sep 02 '25	Sale	1.60	7,936	12,698	208,489	Sep 03 05:12 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Sep 02 '25	Sale	1.60	6,543	10,469	379,788	Sep 03 05:10 PM
Lehman David Aaron	GENERAL COUNSEL	Sep 02 '25	Sale	1.60	9,769	15,630	263,270	Sep 03 05:08 PM
Ferrari Richard	Director	Jun 12 '25	Sale	3.16	8,000	25,280	87,024	Jun 13 05:38 PM
Ferrari Richard	Director	Jun 13 '25	Proposed Sale	3.01	5,438	16,368		Jun 13 11:47 AM
RICH FERRARI	Director	Jun 12 '25	Proposed Sale	3.16	8,000	25,307		Jun 12 05:24 PM
Florin Daniel P	Director	Jun 05 '25	Buy	3.06	23,321	71,362	117,231	Jun 05 08:39 PM
Williamson Steven S.	PRESIDENT AND CEO	Jun 02 '25	Sale	3.13	9,923	31,059	366,115	Jun 04 06:13 PM
Joshi Mehul	Chief Financial Officer & PAO	Jun 02 '25	Sale	3.13	8,061	25,231	213,925	Jun 04 06:10 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 02 '25	Sale	3.13	6,947	21,748	386,331	Jun 04 06:04 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 02 '25	Sale	3.13	10,457	32,736	273,039	Jun 04 06:02 PM

BEAT

HeartBeam Inc

LUNG

Pulmonx Corp

Upgrade your Finviz experience